Book contents
- Frontmatter
- Contents
- Preface
- Contributors
- Part I Clinical Syndromes – General
- Part II Clinical Syndromes – Head and Neck
- Part III Clinical Syndromes – Eye
- Part IV Clinical Syndromes – Skin and Lymph Nodes
- Part V Clinical Syndromes – Respiratory Tract
- Part VI Clinical Syndromes – Heart and Blood Vessels
- Part VII Clinical Syndromes – Gastrointestinal Tract, Liver, and Abdomen
- Part VIII Clinical Syndromes – Genitourinary Tract
- Part IX Clinical Syndromes – Musculoskeletal System
- Part X Clinical Syndromes – Neurologic System
- Part XI The Susceptible Host
- Part XII HIV
- Part XIII Nosocomial Infection
- Part XIV Infections Related to Surgery and Trauma
- Part XV Prevention of Infection
- Part XVI Travel and Recreation
- Part XVII Bioterrorism
- Part XVIII Specific Organisms – Bacteria
- Part XIX Specific Organisms – Spirochetes
- Part XX Specific Organisms – Mycoplasma and Chlamydia
- Part XXI Specific Organisms – Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific Organisms – Fungi
- Part XXIII Specific Organisms – Viruses
- Part XXIV Specific Organisms – Parasites
- 193 Intestinal Roundworms
- 194 Tissue Nematodes
- 195 Schistosomes and Other Trematodes
- 196 Tapeworms (Cestodes)
- 197 Toxoplasma
- 198 Malaria: Treatment and Prophylaxis
- 199 Human Babesiosis
- 200 Trypanosomiases and Leishmaniases
- 201 Intestinal Protozoa
- 202 Extraintestinal Amebic Infection
- Part XXV Antimicrobial Therapy – General Considerations
- Index
201 - Intestinal Protozoa
from Part XXIV - Specific Organisms – Parasites
Published online by Cambridge University Press: 05 March 2013
- Frontmatter
- Contents
- Preface
- Contributors
- Part I Clinical Syndromes – General
- Part II Clinical Syndromes – Head and Neck
- Part III Clinical Syndromes – Eye
- Part IV Clinical Syndromes – Skin and Lymph Nodes
- Part V Clinical Syndromes – Respiratory Tract
- Part VI Clinical Syndromes – Heart and Blood Vessels
- Part VII Clinical Syndromes – Gastrointestinal Tract, Liver, and Abdomen
- Part VIII Clinical Syndromes – Genitourinary Tract
- Part IX Clinical Syndromes – Musculoskeletal System
- Part X Clinical Syndromes – Neurologic System
- Part XI The Susceptible Host
- Part XII HIV
- Part XIII Nosocomial Infection
- Part XIV Infections Related to Surgery and Trauma
- Part XV Prevention of Infection
- Part XVI Travel and Recreation
- Part XVII Bioterrorism
- Part XVIII Specific Organisms – Bacteria
- Part XIX Specific Organisms – Spirochetes
- Part XX Specific Organisms – Mycoplasma and Chlamydia
- Part XXI Specific Organisms – Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific Organisms – Fungi
- Part XXIII Specific Organisms – Viruses
- Part XXIV Specific Organisms – Parasites
- 193 Intestinal Roundworms
- 194 Tissue Nematodes
- 195 Schistosomes and Other Trematodes
- 196 Tapeworms (Cestodes)
- 197 Toxoplasma
- 198 Malaria: Treatment and Prophylaxis
- 199 Human Babesiosis
- 200 Trypanosomiases and Leishmaniases
- 201 Intestinal Protozoa
- 202 Extraintestinal Amebic Infection
- Part XXV Antimicrobial Therapy – General Considerations
- Index
Summary
Intestinal protozoal infection produces substantial morbidity and mortality in people of all ages, particularly in tropical and subtropical parts of the world. Amebiasis, giardiasis, cryptosporidiosis, and those infections associated with acquired immunodeficiency syndrome (AIDS) are important problems for health in many parts of the world, but some protozoa found in the human digestive system do not cause disease. Vaccines are not yet available for protection against these infections, and many are difficult to treat. The intestinal protozoa that produce important human infections are summarized in Table 201.1.
ENTAMEBA HISTOLYTICA
Entameba histolytica causes dysentery, chronic colonic amebiasis, and hepatic amebiasis. The last topic is dealt with in Chapter 202, Extraintestinal Amebic Infection. Amebic dysentery is a syndrome of bloody diarrhea caused by invasion of the colonic wall by trophozoites of E. histolytica. It is common in many parts of the world, especially West and southern Africa, Central America, and south Asia. In the United States, 3000 to 4000 cases are reported each year. There is now consensus that the species formerly recognized as E. histolytica in fact comprises two species: E. histolytica and E. dispar. The first is the pathogenic protozoan long associated with human invasive disease and with hepatic amebiasis, and the latter is a morphologically identical nonpathogenic protozoan first recognized as the nonpathogenic zymodeme of E. histolytica. The latter does not require treatment, but it cannot be differentiated from E. histolytica morphologically.
- Type
- Chapter
- Information
- Clinical Infectious Disease , pp. 1399 - 1404Publisher: Cambridge University PressPrint publication year: 2008